Climate Change Data Portal
DOI | 10.1073/pnas.2008007118 |
Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections | |
Berryhill B.A.; Huseby D.L.; McCall I.C.; Hughes D.; Levin B.R. | |
发表日期 | 2021 |
ISSN | 00278424 |
卷号 | 118期号:10 |
英文摘要 | In response to increasing frequencies of antibiotic-resistant pathogens, there has been a resurrection of interest in the use of bacteriophage to treat bacterial infections: phage therapy. Here we explore the potential of a seemingly ideal phage, PYOSa, for combination phage and antibiotic treatment of Staphylococcus aureus infections. This K-like phage has a broad host range; all 83 tested clinical isolates of S.aureus tested were susceptible to PYOSa. Because of the mode of action of PYOSa, S. aureus is unlikely to generate classical receptor-site mutants resistant to PYOSa; none were observed in the 13 clinical isolates tested. PYOSa kills S. aureus at high rates. On the downside, the results of our experiments and tests of the joint action of PYOSa and antibiotics raise issues that must be addressed before PYOSa is employed clinically. Despite the maintenance of the phage, PYOSa does not clear populations of S. aureus. Due to the ascent of a phenotyically diverse array of small-colony variants following an initial demise, the bacterial populations return to densities similar to that of phage-free controls. Using a combination of mathematical modeling and in vitro experiments, we postulate and present evidence for a mechanism to account for the demise–resurrection dynamics of PYOSa and S. aureus. Critically for phage therapy, our experimental results suggest that treatment with PYOSa followed by bactericidal antibiotics can clear populations of S. aureus more effectively than the antibiotics alone. © 2021 National Academy of Sciences. All rights reserved. |
英文关键词 | Phage therapy; Population dynamics; Staphylococcus aureus |
语种 | 英语 |
scopus关键词 | antibiotic agent; antibiotic sensitivity; Article; bacterium isolate; controlled study; genetic variability; in vitro study; mathematical model; microarray analysis; nonhuman; phage therapy; priority journal; Staphylococcus aureus; Staphylococcus aureus infection |
来源期刊 | Proceedings of the National Academy of Sciences of the United States of America
![]() |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/180365 |
作者单位 | Department of Biology, Emory University, Atlanta, GA 30322, United States; Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, Uppsala, 751 23, Sweden |
推荐引用方式 GB/T 7714 | Berryhill B.A.,Huseby D.L.,McCall I.C.,et al. Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections[J],2021,118(10). |
APA | Berryhill B.A.,Huseby D.L.,McCall I.C.,Hughes D.,&Levin B.R..(2021).Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections.Proceedings of the National Academy of Sciences of the United States of America,118(10). |
MLA | Berryhill B.A.,et al."Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections".Proceedings of the National Academy of Sciences of the United States of America 118.10(2021). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。